Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 70Rectal Neoplasms 29Colonic Neoplasms 28Carcinoma, Hepatocellular 26Neoplasm Metastasis 15Stomach Neoplasms 12Pancreatic Neoplasms 7Cholangiocarcinoma 6Adenocarcinoma Of Esophagus 6Esophageal Neoplasms 5Recurrence 4Liver Neoplasms 4Biliary Tract Neoplasms 4Neoplasms 3Esophageal Squamous Cell Carcinoma 3Peritoneal Neoplasms 2Neoplastic Cells, Circulating 2Gastrointestinal Neoplasms 2Colorectal Cancer Metastatic 2Cirrhosis, Familial, with Pulmonary Hypertension 2Adenocarcinoma 2Postoperative Complications 1Peripheral Nervous System Diseases 1Pathologic Complete Response 1Pancreatic Adenocarcinoma 1Operable T2-3N+M0 Rectal Cancer (Stage III) 1Oligometastatic Gastric Adenocarcinoma 1Neurotoxicity Syndromes 1Neuropathy, Painful 1Neuralgia 1

Interventions

Nivolumab 2pembrolizumab 1folfirinox 1durvalumab 1Trastuzumab 1Single Person 1Paclitaxel 1Irinotecan 1IFL protocol 1Folfox protocol 1Docetaxel 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Gastroesophageal Adenocarcinoma × Folfox protocol × Clear all
NCT05733689 2026-03-10

Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)

University of California, Irvine

Phase 1 Recruiting
20 enrolled
Gastrointestinal

Gastroesophageal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡